Skip to main content

Table 4 Antimicrobial resistance profiles of individual colistin-resistant bacterial strains from animal and human sources

From: Emergence of plasmid-mediated mcr genes from Gram-negative bacteria at the human-animal interface

Antibiotics E. coli K. pneumoniae P. aeruginosa A. baumannii P. mirabilis
Animal Human Animal Human Animal Human Animal Human Animal Human
(n = 91) (n = 3) (n =12) (n = 1) (n = 2) (n = 0) (n = 0) (n = 3) (n = 20) (n = 10)
Co-trimoxazole 64 (70%) 3 (100%) 5 (42%) 1 (100%) 2 (100%) 3 (100%) 8 (40%) 10 (100%)
Chloramphenicol 64 (70%) 3 (100%) 5 (42%) 1 (100%) 2 (100%) 3 (100%) 8 (40%) 4 (40%)
Moxifloxacin 59 (65%) 2(67%) 5 (42%) 1 (100%) 2 (100%) 3 (100%) 3 (15%) 4 (40%)
Levofloxacin 21 (23%) 1 (33%) 3 (25%) 1 (100%) 2 (100%) 2 (75%) 3 (15%) 1 (10%)
Ciprofloxacin 38 (42%) 0 (0%) 2 (17%) 1 (100%) 2 (100%) 3 (100%) 5 (25%) 1 (10%)
Co-amoxiclav 39 (43%) 2 (67%) 1 (8%) 1 (100%) 0 (0%) 3 (100%) 6 (30%) 1 (10%)
Cefotaxime 35 (38%) 1 (33%) 1 (8%) 1 (100%) 0 (0%) 2 (75%) 3 (15%) 1 (10%)
Cefixime 29 (32%) 2 (67%) 3 (25%) 1 (100%) 0 (0%) 3 (100%) 6 (30%) 3 (30%)
Cefuroxime 27 (30%) 2 (67%) 0 (0%) 1 (100%) 0 (0%) 3 (100%) 7 (35%) 3 (30%)
Ceftriaxone 27 (30%) 2 (67%) 1 (8%) 1 (100%) 0 (0%) 3 (100%) 7 (35%) 3 (30%)
Ceftazidime 27 (30%) 1 (33%) 0 (0%) 1 (100%) 0 (0%) 3 (100%) 1 (5%) 3 (30%)
Amikacin 16 (18%) 1 (33%) 3 (25%) 1 (100%) 0 (0%) 2 (75%) 2 (10%) 0 (0%)
Imipenem 12 (13%) 1 (33%) 3 (25%) 1 (100%) 0 (0%) 1 (33%) 0 (0%) 2 (20%)
Cefoperazone-sulbactam 7 (8%) 1 (33%) 2 (17%) 1 (100%) 1 (50%) 2 (67%) 2 (10%) 0 (0%)
Piperacillin-tazobactam 9 (10%) 0 (0%) 0 (0%) 1 (100%) 0 (0%) 0 (0%) 2 (10%) 1 (10%)
Meropenem 9 (10%) 1 (33%) 1 (8%) 1 (100%) 0 (0%) 3 (100%) 2 (10%) 0 (0%)